SOURCE: Bio-Rad Laboratories

February 01, 2007 08:00 ET

Bio-Rad to Report Fourth Quarter and Full Year 2006 Financial Results Thursday, February 22, 2007

HERCULES, CA -- (MARKET WIRE) -- February 1, 2007 -- Bio-Rad Laboratories, Inc. (AMEX: BIO) (AMEX: BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, will report financial results for the fourth quarter and full year 2006 on Thursday, February 22, 2007, after the close of the market. The company will discuss these results in a conference call scheduled for 2 p.m. Pacific Standard Time (5 p.m. Eastern Standard Time) that day.

Interested parties can access the call by dialing 800-265-0241 (in the U.S.) or 617-847-8704 (international), access number 86039052. The live webcast can be accessed at A replay of the call will be available at 888-286-8010 (in the U.S.), or 617-801-6888 (international), access number 21671774 for seven days following the call, and the webcast can be accessed at for 30 days.

About Bio-Rad

Bio-Rad Laboratories, Inc. (AMEX: BIO) (AMEX: BIOb), has remained at the center of scientific discovery for more than 50 years manufacturing and distributing a broad range of products for the life science research and clinical diagnostics markets. The company is renowned worldwide among hospitals, universities, major research institutions as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The company employs over 5,000 people globally and had revenues of $1.1 billion in 2005. For more information, visit

Various statements made within this press release may constitute "forward-looking statements" for the purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. The forward-looking statements contained herein involve risks and uncertainties that could cause results to differ materially from the Company's expectation.

Contact Information

  • For more information contact:
    Christine Tsingos
    Vice President and Chief Financial Officer
    Ron Hutton
    Bio-Rad Laboratories, Inc.
    Email Contact